These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 2576317)
1. Actions of typical and atypical antipsychotics on tuberoinfundibular dopamine neurons. Gudelsky GA; Berry SA; Meltzer HY Psychopharmacol Bull; 1989; 25(3):377-82. PubMed ID: 2576317 [TBL] [Abstract][Full Text] [Related]
2. Activation of tuberoinfundibular dopamine neurons following the acute administration of atypical antipsychotics. Gudelsky GA; Meltzer HY Neuropsychopharmacology; 1989 Mar; 2(1):45-51. PubMed ID: 2572233 [TBL] [Abstract][Full Text] [Related]
3. Basic biology of clozapine: electrophysiological and neuroendocrinological studies. Gudelsky GA; Nash JF; Berry SA; Meltzer HY Psychopharmacology (Berl); 1989; 99 Suppl():S13-7. PubMed ID: 2682728 [TBL] [Abstract][Full Text] [Related]
4. D1 receptors function to inhibit the activation of tuberoinfundibular dopamine neurons. Berry SA; Gudelsky GA J Pharmacol Exp Ther; 1990 Aug; 254(2):677-82. PubMed ID: 1974647 [TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
6. Effect of amperozide on the dopamine synthesis activity in the tuberoinfundibular neurons. Andersson G; Albinsson A; Pettersson G Arzneimittelforschung; 1990 Mar; 40(3):237-9. PubMed ID: 2111999 [TBL] [Abstract][Full Text] [Related]
7. Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatum. Ma J; Ye N; Cohen BM Neuroscience; 2006 Sep; 141(3):1469-80. PubMed ID: 16781818 [TBL] [Abstract][Full Text] [Related]
8. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats. Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395 [TBL] [Abstract][Full Text] [Related]
9. Atypical and typical antipsychotic drug interactions with the dopamine D2 receptor. Hjerde E; Dahl SG; Sylte I Eur J Med Chem; 2005 Feb; 40(2):185-94. PubMed ID: 15694653 [TBL] [Abstract][Full Text] [Related]
10. Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile. Meltzer HY; Gudelsky GA Arzneimittelforschung; 1992 Feb; 42(2A):268-72. PubMed ID: 1586397 [TBL] [Abstract][Full Text] [Related]
11. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle. Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077 [TBL] [Abstract][Full Text] [Related]
12. The effects of typical and atypical antipsychotic drugs on neurotensin-containing neurons in the central nervous system. Kinkead B; Nemeroff CB J Clin Psychiatry; 1994 Sep; 55 Suppl B():30-2. PubMed ID: 7961568 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics. Bardin L; Auclair A; Kleven MS; Prinssen EP; Koek W; Newman-Tancredi A; Depoortère R Behav Pharmacol; 2007 Mar; 18(2):103-18. PubMed ID: 17351418 [TBL] [Abstract][Full Text] [Related]
14. Chronic clozapine, but not haloperidol, alters the response of mesoprefrontal dopamine neurons to stress and clozapine challenges in rats. Morrow BA; Rosenberg SJ; Roth RH Synapse; 1999 Oct; 34(1):28-35. PubMed ID: 10459169 [TBL] [Abstract][Full Text] [Related]
15. Effects of amfonelic acid and GBR 12909 on the haloperidol- and clozapine-induced activation of dopamine neurons. Gudelsky GA; Nwajei EE; Defife K; Nash JF Psychopharmacol Bull; 1992; 28(3):275-9. PubMed ID: 1480731 [TBL] [Abstract][Full Text] [Related]
16. Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain. Oka T; Hamamura T; Lee Y; Miyata S; Habara T; Endo S; Taoka H; Kuroda S Life Sci; 2004 Nov; 76(2):225-37. PubMed ID: 15519367 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of various typical and atypical antipsychotic drugs on the suppressant action of 2-methylserotonin on medial prefrontal cortical cells in the rat. Ashby CR; Minabe Y; Edwards E; Wang RY Synapse; 1991 Jul; 8(3):155-61. PubMed ID: 1683017 [TBL] [Abstract][Full Text] [Related]
19. Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat. Gudelsky GA; Berry SA; Meltzer HY Neuroendocrinology; 1989 Jun; 49(6):604-9. PubMed ID: 2549437 [TBL] [Abstract][Full Text] [Related]
20. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents. Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]